{"title":"FREQUENCY OF CHOLELITHIASIS - RELATED COMPLICATIONS IN MALE GENDER ATTENDING SURGICAL DEPARTMENT AT KING KHALID GENERAL HOSPITAL, MAJMAAH, KSA","authors":"F. Alqahtani","doi":"10.20959/WJPR201711-9538","DOIUrl":null,"url":null,"abstract":"Introduction: Gallstone disease known as cholelithiasis is one of the most common Biliary Tract disorder. Cholelithiasis is common with the incidence ranging from 10% to 20% of the world population, 11% of the general population of the US. The burden of gallstone disease and its complications, such as cholecystitis, pancreatitis, and cholangitis, are major public health issues globally. Objectives: This study aimed at determining the frequency of cholelithiasis-related complications in males admitted to surgical department at King Khalid General Hospital and assessing outcomes of male patients presented with cholelithiasis-related complications following case-tailored management. Methodology: It was a Retrospective descriptive, facility-based study to estimate the frequency and evaluation of cholelithiasis-related complications in males hospitalised in surgical department at King Khalid General Hospital, Majmaah, Saudi Arabia, January 2014December 2016. Results: 83 males were enrolled in our study, with their age groups being ranged from 19 to 99 years (M = 45.55, SD = 16.34). 5 different Complications were reported in our sample of interest. the majority, around 44.6%, suffered from Biliary colic followed by Acute cholecystitis (30.1%), Choledocholithiasis (13.3%), Chronic cholecystitis (8.4%) and Acute pancreatitis (3.6%) respectively. Following their treatment course, patients’ outcomes were as follow: 74 patients have improved while 4 needed to be transferred to another healthcare facility, 4 were HAMA (Home Against Medical Advice) World Journal of Pharmaceutical Research SJIF Impact Factor 7.523 Volume 6, Issue 11, 1-8. Research Article ISSN 2277– 7105 Article Received on 25 July 2017, Revised on 15 August 2017, Accepted on 04 Sept. 2017 DOI: 10.20959/wjpr201711-9538","PeriodicalId":23796,"journal":{"name":"World journal of pharmaceutical research","volume":"35 1","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of pharmaceutical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20959/WJPR201711-9538","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Gallstone disease known as cholelithiasis is one of the most common Biliary Tract disorder. Cholelithiasis is common with the incidence ranging from 10% to 20% of the world population, 11% of the general population of the US. The burden of gallstone disease and its complications, such as cholecystitis, pancreatitis, and cholangitis, are major public health issues globally. Objectives: This study aimed at determining the frequency of cholelithiasis-related complications in males admitted to surgical department at King Khalid General Hospital and assessing outcomes of male patients presented with cholelithiasis-related complications following case-tailored management. Methodology: It was a Retrospective descriptive, facility-based study to estimate the frequency and evaluation of cholelithiasis-related complications in males hospitalised in surgical department at King Khalid General Hospital, Majmaah, Saudi Arabia, January 2014December 2016. Results: 83 males were enrolled in our study, with their age groups being ranged from 19 to 99 years (M = 45.55, SD = 16.34). 5 different Complications were reported in our sample of interest. the majority, around 44.6%, suffered from Biliary colic followed by Acute cholecystitis (30.1%), Choledocholithiasis (13.3%), Chronic cholecystitis (8.4%) and Acute pancreatitis (3.6%) respectively. Following their treatment course, patients’ outcomes were as follow: 74 patients have improved while 4 needed to be transferred to another healthcare facility, 4 were HAMA (Home Against Medical Advice) World Journal of Pharmaceutical Research SJIF Impact Factor 7.523 Volume 6, Issue 11, 1-8. Research Article ISSN 2277– 7105 Article Received on 25 July 2017, Revised on 15 August 2017, Accepted on 04 Sept. 2017 DOI: 10.20959/wjpr201711-9538